SEI Investments
LRMR icon

SEI Investments’s Larimar Therapeutics LRMR Stock Holding History

SEI Investments’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.2K Sell
10,573
-5,763
-35% -$22.9K ﹤0.01% 3246
2026
Q1 		$73.5K Buy
16,336
+5,763
+55% +$23K ﹤0.01% 3139
2025
Q4 		$40.3K Hold
10,573
– – ﹤0.01% 3090
2025
Q3 		$34.2K Hold
10,573
– – ﹤0.01% 2801
2025
Q2 		$30.6K Hold
10,573
– – ﹤0.01% 2772
2025
Q1 		$22.7K Hold
10,573
– – ﹤0.01% 2735
2024
Q4 		$40.9K Hold
10,573
– – ﹤0.01% 2680
2024
Q3 		$69.3K Buy
+10,573
New +$85K ﹤0.01% 2605

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

SEI Investments's LRMR Position: Q2 2026 in Review

SEI Investments reduced its Larimar Therapeutics (LRMR) stake by 35% in Q2 2026, selling an estimated $22.9K and leaving 10,573 shares worth $32.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3246.

SEI Investments first reported a position in LRMR in Q3 2024 and has held it in 8 quarters since. The position peaked at $73.5K in Q1 2026. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • SEI Investments held 10,573 shares of Larimar Therapeutics worth $32.2K as of Q2 2026.
  • SEI Investments sold 5,763 Larimar Therapeutics shares in Q2 2026, an estimated $22.9K.
  • Larimar Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3246 holding.
  • SEI Investments first reported a position in Larimar Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • SEI Investments's Larimar Therapeutics position peaked at $73.5K in Q1 2026.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.